Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection
A. Perez-Gomez, J. Vitalle, M. d. C. Gasca-Capote, A. Gutierrez-Valencia, M. Trujillo-Rodriguez, A. Serna-Gallego, E. Munoz-Muela, M. d. l. R. Jimenez-Leon, M. Rafii-El-Idrissi Benhnia, I. Rivas-Jeremias, C. Sotomayor, C. Roca-Oporto, N. Espinosa, C. Infante-Dominguez, J. C. Crespo-Rivas, , E. Ruiz-Mateos
This study shows that dendritic cell deficiencies and marker alterations persist seven months after SARS-CoV-2 infection in previously hospitalized and non-hospitalized patients.
bioRxiv · Mar 18, 2021 · PreprintImmunology